To advise of a Serious Shortage Protocol (SSP) in place for Estradot® (Estradiol hemihydrate) 100 microgram patches, from 21 August 2023 to 8 September 2023.

This Circular advises community pharmacy contractors that the Serious Shortage Protocol (SSP) for Progynova®

This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Utrogestan® (micronised progesterone) 100mg capsules

Two of the UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic products due to expire on 21 July 2023 have now been extended

The UK-wide active Serious Shortage Protocol (SSP) for Progynova® (estradiol) TS 100 microgram patches, a hormone replacement therapy (HRT)

This Circular advises NHS Boards and community pharmacy contractors that ten of the UK-wide Serious Shortage Protocols (SSPs) for antibiotics products due to expire on 28 April 2023 have now been extended.

This Circular advises NHS Boards and community pharmacy contractors that five of the UK-wide Serious Shortage Protocols (SSPs) for Phenoxymethylpenicillin products that were issued on 16 December (SSPs 043-047) have been amended to allow pharmacists to supply azithromycin as a further alternative antibiotic. The expiry date for the amended SSPs still remains the 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 250mg tablets, from 16 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 250mg/5ml oral solution sugar free, from 16 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 250mg/5ml oral solution, from 16 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 125mg/5ml oral solution sugar free, from 16 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 125mg/5ml oral solution, from 15 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 250mg/5ml oral solution, from 15 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 250mg/5ml oral solution sugar free, from 15 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 125mg/5ml oral solution sugar free, from 15 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Estraderm MX® 75 microgram patch, from 15 November 2022 to 13 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Estraderm MX® 50 microgram patch, from 15 November 2022 to 13 January 2023.

This Circular advises NHS Boards and community pharmacy contractors that the 12 UK-wide active Serious Shortage Protocols (SSPs) for HRT products due to expire on 28 October 2022, have now been extended.

The Scottish Government have released Circular PAC(P)(2022)29 which advises of an extension to the Serious Shortage Protocol (SSP) in place for Estraderm MX® 100 microgram patch, in place from 8 September, extended to 30 September 2022.

To advise of an extension to the Serious Shortage Protocol (SSP) in place for Estraderm MX® 25 microgram patch, in place from 8 September, extended to 30 September 2022.